Author
Listed:
- Shantanu Banerji
(The Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Harvard Medical School
Present addresses: Department of Medical Oncology, CancerCare Manitoba, Winnipeg, Manitoba R3E 0V9, Canada (S.B.); Global Biotech Consulting Group, Mexico City 01900, Mexico (G.J.-S.).)
- Kristian Cibulskis
(The Broad Institute of MIT and Harvard)
- Claudia Rangel-Escareno
(Instituto Nacional de Medicina Genómica)
- Kristin K. Brown
(Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215)
- Scott L. Carter
(The Broad Institute of MIT and Harvard)
- Abbie M. Frederick
(The Broad Institute of MIT and Harvard)
- Michael S. Lawrence
(The Broad Institute of MIT and Harvard)
- Andrey Y. Sivachenko
(The Broad Institute of MIT and Harvard)
- Carrie Sougnez
(The Broad Institute of MIT and Harvard)
- Lihua Zou
(The Broad Institute of MIT and Harvard)
- Maria L. Cortes
(The Broad Institute of MIT and Harvard)
- Juan C. Fernandez-Lopez
(Instituto Nacional de Medicina Genómica)
- Shouyong Peng
(Dana-Farber Cancer Institute)
- Kristin G. Ardlie
(The Broad Institute of MIT and Harvard)
- Daniel Auclair
(The Broad Institute of MIT and Harvard)
- Veronica Bautista-Piña
(Instituto de Enfermedades de la Mama FUCAM)
- Fujiko Duke
(The Broad Institute of MIT and Harvard)
- Joshua Francis
(The Broad Institute of MIT and Harvard)
- Joonil Jung
(The Broad Institute of MIT and Harvard)
- Antonio Maffuz-Aziz
(Instituto de Enfermedades de la Mama FUCAM)
- Robert C. Onofrio
(The Broad Institute of MIT and Harvard)
- Melissa Parkin
(The Broad Institute of MIT and Harvard)
- Nam H. Pho
(The Broad Institute of MIT and Harvard)
- Valeria Quintanar-Jurado
(Instituto Nacional de Medicina Genómica)
- Alex H. Ramos
(The Broad Institute of MIT and Harvard)
- Rosa Rebollar-Vega
(Instituto Nacional de Medicina Genómica)
- Sergio Rodriguez-Cuevas
(Instituto de Enfermedades de la Mama FUCAM)
- Sandra L. Romero-Cordoba
(Instituto Nacional de Medicina Genómica)
- Steven E. Schumacher
(The Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute)
- Nicolas Stransky
(The Broad Institute of MIT and Harvard)
- Kristin M. Thompson
(The Broad Institute of MIT and Harvard)
- Laura Uribe-Figueroa
(Instituto Nacional de Medicina Genómica)
- Jose Baselga
(Harvard Medical School
Massachusetts General Hospital)
- Rameen Beroukhim
(The Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Harvard Medical School
Dana-Farber Cancer Institute)
- Kornelia Polyak
(Dana-Farber Cancer Institute
Harvard Medical School
Brigham and Women’s Hospital)
- Dennis C. Sgroi
(Harvard Medical School
Depertment of Pathology, Massachusetts General Hospital)
- Andrea L. Richardson
(Dana-Farber Cancer Institute
Harvard Medical School
Brigham and Women's Hospital)
- Gerardo Jimenez-Sanchez
(Instituto Nacional de Medicina Genómica
Present addresses: Department of Medical Oncology, CancerCare Manitoba, Winnipeg, Manitoba R3E 0V9, Canada (S.B.); Global Biotech Consulting Group, Mexico City 01900, Mexico (G.J.-S.).)
- Eric S. Lander
(The Broad Institute of MIT and Harvard
Harvard Medical School
Massachusetts Institute of Technology)
- Stacey B. Gabriel
(The Broad Institute of MIT and Harvard)
- Levi A. Garraway
(The Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Harvard Medical School)
- Todd R. Golub
(The Broad Institute of MIT and Harvard
Harvard Medical School
Dana-Farber Cancer Institute
Howard Hughes Medical Institute)
- Jorge Melendez-Zajgla
(Instituto Nacional de Medicina Genómica)
- Alex Toker
(Harvard Medical School
Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215)
- Gad Getz
(The Broad Institute of MIT and Harvard)
- Alfredo Hidalgo-Miranda
(Instituto Nacional de Medicina Genómica)
- Matthew Meyerson
(The Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Harvard Medical School
Dana-Farber Cancer Institute)
Abstract
This paper reports one of the largest breast cancer whole-exome and whole-genome sequencing efforts so far, identifying previously unknown recurrent mutations in CBFB, deletions of RUNX1 and recurrent MAGI1–AKT3 fusion; the fusion suggests that the use of ATP-competitive AKT inhibitors should be evaluated in clinical trials.
Suggested Citation
Shantanu Banerji & Kristian Cibulskis & Claudia Rangel-Escareno & Kristin K. Brown & Scott L. Carter & Abbie M. Frederick & Michael S. Lawrence & Andrey Y. Sivachenko & Carrie Sougnez & Lihua Zou & Ma, 2012.
"Sequence analysis of mutations and translocations across breast cancer subtypes,"
Nature, Nature, vol. 486(7403), pages 405-409, June.
Handle:
RePEc:nat:nature:v:486:y:2012:i:7403:d:10.1038_nature11154
DOI: 10.1038/nature11154
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:486:y:2012:i:7403:d:10.1038_nature11154. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.